Related Experiment Video

Updated: May 23, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

[High maintenance dose of clopidogrel improves long-term clinical outcomes in patients with elective percutaneous

Li-hui Ren1, Jian-jun Peng, Xue-li Xu

  • 1Department of Cardiology, Beijing Shijitan Hospital, Beijing, China.

Zhonghua Yi Xue Za Zhi
|April 12, 2012
PubMed

Insights

A high maintenance dose of 150 mg clopidogrel daily for one month after percutaneous coronary intervention (PCI) significantly reduces major adverse cardiovascular events (MACE). This approach improves platelet inhibition and lowers risks compared to a 75 mg dose.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) is a common procedure for coronary artery disease.
  • Antiplatelet therapy is crucial after PCI to prevent thrombotic events.
  • Optimizing clopidogrel dosage is essential for maximizing efficacy and minimizing risks.

Purpose of the Study:

  • To evaluate the efficacy of a 300 mg loading dose of clopidogrel followed by a 150 mg maintenance dose compared to a 75 mg maintenance dose.
  • To assess the impact of different clopidogrel maintenance doses on platelet inhibition and clinical outcomes post-PCI.
  • To determine the optimal clopidogrel regimen for patients undergoing elective PCI.

Main Methods:

  • A total of 108 patients undergoing elective PCI were enrolled.
  • Patients received a 300 mg clopidogrel loading dose before PCI.
  • Following PCI, patients were randomized to receive either 75 mg (n=55) or 150 mg (n=46) of clopidogrel daily for 30 days, followed by 75 mg daily for up to 6 months.

Main Results:

  • The 150 mg clopidogrel group demonstrated significantly higher platelet inhibition (64.2% ± 13.3%) compared to the 75 mg group (52.6% ± 14.3%) at 30 days (P = 0.00).
  • The incidence of major adverse cardiovascular events (MACE), including death, myocardial infarction (MI), and target vessel revascularization (TVR), was lower in the 150 mg group (13.0%) versus the 75 mg group (20.2%).
  • Specific event rates for MI and TVR were numerically lower in the 150 mg group, although not statistically significant for individual components.

Conclusions:

  • A high clopidogrel maintenance dose of 150 mg daily for the initial month post-PCI is effective in enhancing platelet inhibition.
  • This higher maintenance dose regimen reduces the long-term risk of adverse events in patients undergoing elective PCI.
  • The findings support the use of an intensified clopidogrel regimen in the early period after PCI for improved clinical outcomes.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...